Raju, K RSivasankar, BAnand, VLuthra, KTiwari, S CDinda, A KDas, NSrivastava, L M2009-05-272009-05-272001-03-10Raju KR, Sivasankar B, Anand V, Luthra K, Tiwari SC, Dinda AK, Das N, Srivastava LM. Use of complement receptor 1 (CD35) assay in the diagnosis and prognosis of immune complex mediated glomerulopathies. Asian Pacific Journal of Allergy and Immunology. 2001 Mar; 19(1): 23-7http://imsear.searo.who.int/handle/123456789/36775Published by the Allergy and Immunology Society of Thailand.Complement Receptor 1 (CR1) is a polymorphic glycoprotein expressed on erythrocytes, leukocytes and glomerular podocytes and has a major role in immune complex processing. In addition, it regulates the complement cascade activation by preventing formation of classical and alternative pathway convertases and by acting as a cofactor for Factor I mediated cleavage of C3. In this study, we have examined the expression of erythrocyte CR1 (E-CR1) and glomerular CR1 (G-CR1) in different kinds of nephropathies using ELISA and immunofluorescence microscopy to understand their role in immune complex (IC) mediated renal diseases. E-CR1 was significantly reduced in all categories of lupus nephritis in comparison to normal subjects and non-IC renal diseases. However, other IC mediated diseases like IgA nephropathy and membranoproliferative glomerulonephritis had normal E-CR1 levels. G-CR1 showed distinct differences between IC and non-IC mediated diseases. G-CR1 was virtually absent in lupus kidneys. In other IC mediated diseases, there was a correlation of G-CR1 expression to the IC and complement fragment deposition. G-CR1 serves as a useful diagnostic marker for IC mediated diseases while E-CR1 is useful as a prognostic marker to monitor the course of disease after the treatment has initiated.engErythrocytes --chemistryFemaleFollow-Up StudiesHumansImmune Complex Diseases --diagnosisIndiaKidney Diseases --diagnosisKidney GlomerulusMaleMethodsPrognosisReceptors, Complement --analysisReceptors, Complement 3b --analysisComparative Study